Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ophthalmic Surg Lasers Imaging Retina ; 47(5): 418-25, 2016 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-27183545

RESUMEN

BACKGROUND AND OBJECTIVE: To evaluate glaucomatous changes in patients with diabetic macular edema (DME) treated with intravitreal implants releasing 0.2 µg/day or 0.5 µg/day fluocinolone acetonide (FAc) (Iluvien 0.2 µg/day; Alimera Sciences, Alpharetta, GA) or sham control. PATIENTS AND METHODS: Fundus photographs were assessed to determine clinically significant changes in glaucomatous indicators. RESULTS: The mean cup-to-disc ratio (CDR) change was similar with all three treatments. Compared with sham control, a significantly greater proportion of patients treated with 0.5 µg/day but not 0.2 µg/day FAc experienced a CDR increase of greater than 0.1. There was no significant increase in the proportion of patients experiencing a CDR increase of greater than 0.2 with either dose of implant versus sham control. Other indicators of glaucomatous change did not differ significantly with treatment. Subgroup analyses showed no differences in cupping based on ocular or baseline characteristics. CONCLUSION: Treatment with FAc for 36 months was not associated with significant glaucomatous optic nerve head changes in patients with DME with or without increased intraocular pressure. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:418-425.].


Asunto(s)
Retinopatía Diabética/tratamiento farmacológico , Implantes de Medicamentos , Fluocinolona Acetonida/administración & dosificación , Edema Macular/tratamiento farmacológico , Nervio Óptico/patología , Evaluación de Resultado en la Atención de Salud , Agudeza Visual , Adulto , Anciano , Anciano de 80 o más Años , Retinopatía Diabética/complicaciones , Retinopatía Diabética/diagnóstico , Relación Dosis-Respuesta a Droga , Femenino , Glucocorticoides/administración & dosificación , Humanos , Edema Macular/diagnóstico , Edema Macular/etiología , Masculino , Persona de Mediana Edad , Nervio Óptico/efectos de los fármacos , Resultado del Tratamiento , Cuerpo Vítreo , Adulto Joven
2.
Health Promot Int ; 19(3): 379-87, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15306622

RESUMEN

A broad consensus has emerged in relation to the desirability of promoting exercise among a variety of 'at risk' groups via 'exercise on prescription' (EoP) schemes, as an alternative to orthodox, biomedical approaches to the management of health problems. Underpinning the rationale for such schemes is the notion that they can act as vehicles for encouraging long-term adherence to exercise. Whilst there is a common sense appeal to using EoP schemes to promote exercise, research to date suggests that evidence of their impact is limited. This paper attempts to make sense of these findings in the light of recent debates about adult lifestyles and exercise. More specifically, it brings work in the sociology of leisure to bear on the topic, on the premise that any study of adults' propensity towards sustainable physical activity needs to be viewed as an aspect of their lives 'in the round'. Such an analysis points up the value of synthesizing perspectives from across the disciplinary divide in order to shed light on particular 'problems', which obviate the necessity for further empirical work. The paper concludes by identifying a number of implications for public health policy and practice with respect to the matter of encouraging lifelong participation in sport and exercise in general, and via EoP schemes in particular. One such implication is the development of a model for understanding participation that shifts the emphasis away from a focus on motivation and behaviour change per se towards satisfaction and enjoyment through the development of skills and relationships. Reconceptualizing the matter of participation in this way is likely to lead not only to a more realistic appreciation of what can be expected from EoP schemes, but also a more adequate understanding of adherence to exercise in later life.


Asunto(s)
Terapia por Ejercicio , Ejercicio Físico/psicología , Promoción de la Salud/métodos , Adulto , Factores de Edad , Ejercicio Físico/fisiología , Conocimientos, Actitudes y Práctica en Salud , Humanos , Actividades Recreativas/psicología , Estilo de Vida , Persona de Mediana Edad , Motivación , Aptitud Física/fisiología , Aptitud Física/psicología , Medio Social , Deportes/fisiología , Deportes/psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA